Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.
Moody TW, Nuche-Berenguer B, Jensen RT.
Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):38-47. doi: 10.1097/MED.0000000000000218.
Vasoactive intestinal peptide.
Said SI.
J Endocrinol Invest. 1986 Apr;9(2):191-200. doi: 10.1007/BF03348097.
Vasoactive Intestinal Peptide-Secreting Tumors: A Review.
Siddappa PK, Vege SS.
Pancreas. 2019 Oct;48(9):1119-1125. doi: 10.1097/MPA.0000000000001402.
The role of vasoactive intestinal peptide in pulmonary diseases.
Zhong HL, Li PZ, Li D, Guan CX, Zhou Y.
Life Sci. 2023 Nov 1;332:122121. doi: 10.1016/j.lfs.2023.122121. Epub 2023 Sep 22.
Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice.
Kittikulsuth W, Nakano D, Kitada K, Uyama T, Ueda N, Asano E, Okano K, Matsuda Y, Nishiyama A.
Sci Rep. 2023 Jan 17;13(1):927. doi: 10.1038/s41598-023-28073-6.
Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.
Klippstein R, Pozo D.
Adv Protein Chem Struct Biol. 2015;98:145-68. doi: 10.1016/bs.apcsb.2014.11.006. Epub 2015 Mar 3.
[Vasoactive intestinal peptide-producing tumor (ViPoma)].
Doi R, Tsukada T.
Nihon Rinsho. 2006 Sep 28;Suppl 3:358-62.
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Ravindranathan S, Passang T, Li JM, Wang S, Dhamsania R, Ware MB, Zaidi MY, Zhu J, Cardenas M, Liu Y, Gumber S, Robinson B, Sen-Majumdar A, Zhang H, Chandrakasan S, Kissick H, Frey AB, Thomas SN, El-Rayes BF, Lesinski GB, Waller EK.
Nat Commun. 2022 Oct 27;13(1):6418. doi: 10.1038/s41467-022-34242-4.
Pre-clinical study on tumor vasoactive intestinal peptide receptor scintigraphy.
Wang X, Zhang M, Yang Z, Lin B, Zhang Q.
Zhonghua Zhong Liu Za Zhi. 2002 Jul;24(4):331-4.
Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
Virgolini I, Yang Q, Li S, Angelberger P, Neuhold N, Niederle B, Scheithauer W, Valent P.
Cancer Res. 1994 Feb 1;54(3):690-700.
